PlainRecalls
FDA Drug Moderate Class II Ongoing

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .

Reported: May 28, 2025 Initiated: May 14, 2025 #D-0444-2025

Product Description

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .

Reason for Recall

Defective delivery system

Details

Units Affected
a) 807,837 canisters; b) 235,698 canisters
Distribution
USA Nationwide
Location
Wilmington, DE

Frequently Asked Questions

What product was recalled?
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .. Recalled by AsttraZeneca Pharmaceuticals LP. Units affected: a) 807,837 canisters; b) 235,698 canisters.
Why was this product recalled?
Defective delivery system
Which agency issued this recall?
This recall was issued by the FDA Drug on May 28, 2025. Severity: Moderate. Recall number: D-0444-2025.